Pubblicazioni

Totale pubblicazioni a partire dal 2011: 102


Anno

2019; 20(11):

Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing.

Fabrizio FP, Sparaneo A, Centra F, Trombetta D, Storlazzi CT, Graziano P, Maiello E, Fazio VM, Muscarella LA


2019; 20(12):

Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?

Coco C, Sgarra L, Potenza MA, Nacci C, Pasculli B, Barbano R, Parrella P, Montagnani M


2019; 20(10):

Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors.

Sparaneo A, Fabrizio FP, la Torre A, Graziano P, Di Maio M, Fontana A, Bisceglia M, Rossi A, Pizzolitto S, De Maglio G, Tancredi A, Grimaldi F, Balsamo T, Centra F, Manzorra MC, Trombetta D, Pantalone A, Bonfitto A, Maiello E, Fazio VM, Muscarella LA


2019; 21(1): 20

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.

Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler M


2018; 433(): 242-251

Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1.

Maldonado L, Brait M, Izumchenko E, Begum S, Chatterjee A, Sen T, Loyo M, Barbosa A, Poeta ML, Makarev E, Zhavoronkov A, Fazio VM, Angioli R, Rabitti C, Ongenaert M, Van Criekinge W, Noordhuis MG, de Graeff P, Wisman GBA, van der Zee AGJ, Hoque MO


2018; 10(): 1758835918815598

Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy.

Fabrizio FP, Trombetta D, Rossi A, Sparaneo A, Castellana S, Muscarella LA


2018; 17(1): 169

EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers.

De Robertis M, Mazza T, Fusilli C, Loiacono L, Poeta ML, Sanchez M, Massi E, Lamorte G, Diodoro MG, Pescarmona E, Signori E, Pesole G, Vescovi AL, Garcia-Foncillas J, Fazio VM


2018; 10(11):

In Vivo Evaluation of a New Recombinant Hyaluronidase to Improve Gene Electro-Transfer Protocols for DNA-Based Drug Delivery against Cancer.

De Robertis M, Pasquet L, Loiacono L, Bellard E, Messina L, Vaccaro S, Di Pasquale R, Fazio VM, Rols MP, Teissie J, Golzio M, Signori E


2018; 53(): 232-247

Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells.

De Robertis M, Poeta ML, Signori E, Fazio VM


2018; 12(9): 937-940

The value of epigenetic biomarkers in breast cancer.

Parrella P


2018; 2018(): 2492063

Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.

Fabrizio FP, Sparaneo A, Trombetta D, Muscarella LA


2018; 214(8): 1156-1165

Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.

Muscarella LA, Bisceglia M, Galliani CA, Zidar N, Ben-Dor DJ, Pasquinelli G, la Torre A, Sparaneo A, Fanburg-Smith JC, Lamovec J, Michal M, Bacchi CE


2018; 9(29): 20721-20733

Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion.

Muscarella LA, Turchetti D, Fontana A, Baorda F, Palumbo O, la Torre A, de Martino D, Franco R, Losito NS, Repaci A, Pagotto U, Cinque L, Copetti M, Chiofalo MG, Pezzullo L, Graziano P, Scillitani A, Guarnieri V


2018; :

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression.

Trombetta D, Graziano P, Scarpa A, Sparaneo A, Rossi G, Rossi A, Di Maio M, Antonello D, Mafficini A, Fabrizio FP, Manzorra CM, Balsamo T, Centra F, Simbolo M, Pantalone A, Notarangelo M, Parente P, Dimitri MCL, Bonfitto A, Fiordelisi F, Storlazzi CT, L'A


2018; ():

Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine.

Pasculli B, Barbano R, Parrella P


2017; 18(1): 98

N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration.

Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J,


2017; ():

Extraneuraxial Hemangioblastoma: Clinicopathologic Features and Review of the Literature.

Bisceglia M, Muscarella LA, Galliani CA, Zidar N, Ben-Dor D, Pasquinelli G, la Torre A, Sparaneo A, Fanburg-Smith JC, Lamovec J, Michal M, Bacchi CE


Epigenetic mechanisms in cancer: predictive value of epigenetic Signatures 2017; 3: 275-311

Epigenetic mechanisms in cancer: predictive value of epigenetic Signatures

Pasculli B., Barbano R., Parrella P.

2017; ():

Pharmacokinetic drug evaluation of osimertinib for the treatment of non-small cell lung cancer.

Rossi A M D, Muscarella LA Ph D, Di Micco C M D, Carbonelli C M D, D'Alessandro V M D, Notarangelo S M D, Palomba G M D, Sanpaolo G M D, Taurchini M M D, Graziano P M D, Maiello E M D


2017; ():

MEN1 gene mutation with parathyroid carcinoma: first report of a familial case.

Cinque L, Sparaneo A, Salcuni AS, De Martino DG, Battista C, Logoluso F, Palumbo O, Cocchi R, Maiello E, Graziano P, Hendy G, Cole DEC, Scillitani A, Guarnieri V


2017; ():

Novel Autosomal Dominant PTH Gene Signal Sequence Mutation in a Family with Familial Isolated Hypoparathyroidism.

Cinque L, Sparaneo A, Penta L, Mencarelli A, Rogaia D, Esposito S, Fabrizio FP, Baorda F, Verrotti A, Falorni A, Stangoni G, Hendy GN, Guarnieri V, Prontera P


2017; 12(10): e161-e163

ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma.

Muscarella LA, Trombetta D, Fabrizio FP, Scarpa A, Fazio VM, Maiello E, Rossi A, Graziano P


2017; ():

NRG1-ErbB lost in translation: a new paradigm for lung cancer?

Trombetta D, Rossi A, Fabrizio FP, Sparaneo A, Graziano P, Fazio VM, Muscarella LA


2017; 14(1): 23-30

Novel association of MEN1 gene mutations with parathyroid carcinoma.

Cinque L, Sparaneo A, Cetani F, Coco M, Clemente C, Chetta M, Balsamo T, Battista C, Sanpaolo E, Pardi E, D'Agruma L, Marcocci C, Maiello E, Hendy GN, Cole DEC, Scillitani A, Guarnieri V


2017; ():

Alterations of DNA methylation in parathyroid tumors.

Guarnieri V, Muscarella LA, Verdelli C, Corbetta S


2017; 13(2): 593-598

A malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the EML4-ALK fusion gene.

Muscarella LA, Rossi G, Trombetta D, La Torre A, Di Candia L, Mengoli MC, Sparaneo A, Fazio VM, Graziano P


2017; 7(): 45283

Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients.

Barbano R, Pasculli B, Rendina M, Fontana A, Fusilli C, Copetti M, Castellana S, Valori VM, Morritti M, Graziano P, Luigi C, Coco M, Picardo F, Mazza T, Evron E, Murgo R, Maiello E, Esteller M, Fazio VM, Parrella P


2017; 168(6): 1086-1100.e10

Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation.

Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, Serafini N, Puel A, Bustamante J, Surace L, Masse-Ranson G, David E, Strick-Marchand H, Le Bourhis L, Cocchi R, Topazio D, Graziano P, Muscarella LA, Rogge L, Norel X, Sallenave JM, Allez M,


2017; ():

Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.

Fabrizio FP, Costantini M, Copetti M, la Torre A, Sparaneo A, Fontana A, Poeta L, Gallucci M, Sentinelli S, Graziano P, Parente P, Pompeo V, De Salvo L, Simone G, Papalia R, Picardo F, Balsamo T, Flammia GP, Trombetta D, Pantalone A, Kok K, Paranita F, Mu


2016; 172(6): 980-2

Flow cytometry characterization in central nervous system and pleural effusion multiple myeloma infiltration: an Italian national cancer institute experience.

Marchesi F, Masi S, Summa V, Gumenyuk S, Merola R, Orlandi G, Cigliana G, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, De Bellis F, Conti L, Mengarelli A, Cordone I


2016; :

Keap1/Nrf2 impairing revised: are we missing the single nucleotide polymorphisms?

Muscarella L., Fazio V.M.


2016; ():

BRAF mutations in sarcomatoid and large cell carcinoma of the lung.

Mengoli MC, Bettelli S, Gasparri P, Bertolini F, Barbieri F, Spaltro AA, Manfredini S, Muscarella LA, Graziano P


2016; :

A malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the EML4-ALK fusion gene

Muscarella L., Rossi G., Trombetta D., La Torre A., Di Candia L., Mengoli M.C., Sparaneo A., Fazio V.M., Graziano P.

The American Journal of Pathology 2016; 186 suppl: S12

Keap1/Nrf2 Pathway In Kidney Cancer: Frequent Methylation of Keap1 Gene Promoter In Clear Renal Cell Carcinoma

Fabrizio F., Costantini M., Copetti M., la Torre A., Sparaneo A., Fontana A., Poeta M., Gallucci M., Sentinelli S., Graziano P., Parente P., Pompeo V., De Salvo L., Simone G., Papalia R., Picardo F., Balsamo T., Flammia G.P., Trombetta D., Pantalone A., K

2016; 2016(): 7316492

Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad.

Sparaneo A, Fabrizio FP, Muscarella LA


2016; 6(): 31549

Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia.

Palmieri O, Mazza T, Merla A, Fusilli C, Cuttitta A, Martino G, Latiano T, Corritore G, Bossa F, Palumbo O, Muscarella LA, Carella M, Graziano P, Andriulli A, Latiano A


Lung Cancer Management 2016; :

Liquid biopsy and NSCLC

Trombetta D., Sparaneo A., Fabrizio F.P., Muscarella L.

2016; ():

Dysregulation of EGFR pathway in EphA2 cell subpopulation significantly associates with poor prognosis in colorectal cancer.

De Robertis M, Loiacono L, Fusilli C, Poeta ML, Mazza T, Sanchez M, Marchionni L, Signori E, Lamorte G, Vescovi AL, Garcia-Foncillas J, Fazio VM


2016; ():

Analysis of clock gene-miRNA correlation networks reveals candidate drivers in colorectal cancer.

Mazzoccoli G, Colangelo T, Panza A, Rubino R, Tiberio C, Palumbo O, Carella M, Trombetta D, Gentile A, Tavano F, Valvano MR, Storlazzi CT, Macchia G, De Cata A, Bisceglia G, Capocefalo D, Colantuoni V, Sabatino L, Piepoli A, Mazza T


2016; (): 0

BRAF V600E mutation in metastatic colorectal cancer: methods of detection and correlation with clinical and pathologic features.

Roma C, Rachiglio AM, Pasquale R, Fenizia F, Iannaccone A, Tatangelo F, Antinolfi G, Parrella P, Graziano P, Sabatino L, Colantuoni V, Botti G, Maiello E, Normanno N


2016; ():

EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.

Sanpaolo E, Miroballo M, Corbetta S, Verdelli C, Baorda F, Balsamo T, Graziano P, Fabrizio FP, Cinque L, Scillitani A, Muscarella LA, Guarnieri V


2016; :

Deregulated expression of cryptochrome genes in human colorectal cancer

Mazzoccoli G., Colangelo T., Panza A., Rubino A., De Cata A., Tiberio C., Valvano M.R., Pazienza V., Merla G., Augello B., Trombetta D., Storlazzi C.T., Macchia G., Gentile A., Tavano F., Vinciguerra M., Bisceglia G., Rosato V., Colantuoni V., sabatino L.


64 Congresso Nazionale SINCH 24_26 Giugno 2016 Napoli 2015; :

Ruolo dello stato di metilazione del gene KEAP1 nella prognosi dei gliomi maligni.

Icolaro N., PArrella P., Barbano R., Muscarella L., Barbara P., Copetti M., Catapano D., Fazio V.M., d'Angelo V.

64 Congresso Nazionale SINCH Napoli 24_26 Giugno 2016 2015; :

Identificazione di un pannello di miRNA associato al ?Fenotipo Aggressivo? ed alla prognosi dei gliomi.

Icolaro N., Parrella P., Barbano R., Palumbo O., Pasculli B., Copetti M., Carella M., Fazio V.M., D'Angelo V.

2015; 77(6): 481-5

The Post-Surgical Long-Term Behaviour of Lung Carcinoid Tumours.

Tancredi A, Muscarella LA, la Torre A, Scaramuzzi R, Valori VM, Fazio VM, Scaramuzzi G


2015; :

Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.

Barbano R., Pasculli B., Coco M., Fontana A., Copetti M., Rendina M., Valori V.M., Graziano P., Maiello E., Fazio V.M., Parrella P.


2015; 13(): 17

Human neural stem cell transplantation in ALS: initial results from a phase I trial.

Mazzini L, Gelati M, Profico DC, Sgaravizzi G, Projetti Pensi M, Muzi G, Ricciolini C, Rota Nodari L, Carletti S, Giorgi C, Spera C, Domenico F, Bersano E, Petruzzelli F, Cisari C, Maglione A, Sarnelli MF, Stecco A, Querin G, Masiero S, Cantello R, Ferrar


2015; 105(): 274-288

Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.

Sestito S, Nesi G, Daniele S, Martelli A, Digiacomo M, Borghini A, Pietra D, Calderone V, Lapucci A, Falasca M, Parrella P, Notarangelo A, Breschi MC, Macchia M, Martini C, Rapposelli S


2015; :

The post surgical long term behaviour of lung carcinoid tumors

Tancredi A., Muscarella L.A., La Torre A., Scaramuzzi R., Valori V.M., Fazio V.M., Scaramuzzi G.

2015; ():

The speed of swelling kinetics modulates cell volume regulation and calcium signaling in astrocytes: A different point of view on the role of aquaporins.

Mola MG, Sparaneo A, Gargano CD, Spray DC, Svelto M, Frigeri A, Scemes E, Paola Nicchia G


2015; 524(7563): 47-53

Comprehensive genomic profiles of small cell lung cancer.

George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, Leenders F, Lu X, Fernández-Cuesta L, Bosco G, Müller C, Dahmen I, Jahchan NS, Park KS, Yang D, Karnezis AN, Vaka D, Torres A, Wang MS, Korbel JO, Menon R, Chun SM, Kim D, Wilkerson M, Hayes N, Engelman


2015; 15(): 470

TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival.

Micale L, Fusco C, Fontana A, Barbano R, Augello B, De Nittis P, Copetti M, Pellico MT, Mandriani B, Cocciadiferro D, Parrella P, Fazio VM, Dimitri LM, D'Angelo V, Novielli C, Larizza L, Daga A, Merla G


2014; (): jc20142857

Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.

D'Agruma L, Coco M, Guarnieri V, Battista C, Canaff L, Salcuni AS, Corbetta S, Cetani F, Minisola S, Chiodini I, Eller-Vainicher C, Spada A, Marcocci C, Guglielmi G, Zini M, Clemente R, Wong BY, de Martino D, Scillitani A, Hendy GN, Cole DE


2014; 14(): 396

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities.

L'Abbate A, Lo Cunsolo C, Macrì E, Iuzzolino P, Mecucci C, Doglioni C, Coco M, Muscarella LA, Salati S, Tagliafico E, Minoia C, De Tullio G, Guarini A, Testoni N, Agostinelli C, Storlazzi CT


2014; 9(10): e108950

A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas.

Barbano R, Palumbo O, Pasculli B, Galasso M, Volinia S, D'Angelo V, Icolaro N, Coco M, Dimitri L, Graziano P, Copetti M, Valori VM, Maiello E, Carella M, Fazio VM, Parrella P


2014; 37(4): 281-8

A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.

Chiofalo MG, Sparaneo A, Chetta M, Franco R, Baorda F, Cinque L, Granatiero M, D'Agruma L, Pezzullo L, Scillitani A, Guarnieri V


2014; ():

Genomic organization and evolution of double minutes/homogeneously staining regions with MYC amplification in human cancer.

L'Abbate A, Macchia G, D'Addabbo P, Lonoce A, Tolomeo D, Trombetta D, Kok K, Bartenhagen C, Whelan CW, Palumbo O, Severgnini M, Cifola I, Dugas M, Carella M, Bellis GD, Rocchi M, Carbone L, Storlazzi CT


2014; 13(): 142

Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.

Parrella P, Barbano R, Pasculli B, Fontana A, Copetti M, Valori VM, Poeta ML, Perrone G, Righi D, Castelvetere M, Coco M, Balsamo T, Morritti M, Pellegrini F, Onetti-Muda A, Maiello E, Murgo R, Fazio VM


2014; 4(4): 415-22

CD74-NRG1 Fusions in Lung Adenocarcinoma.

Fernandez-Cuesta L, Plenker D, Osada H, Sun R, Menon R, Leenders F, Ortiz-Cuaran S, Peifer M, Bos M, Daßler J, Malchers F, Schöttle J, Vogel W, Dahmen I, Koker M, Ullrich RT, Wright GM, Russell PA, Wainer Z, Solomon B, Brambilla E, Nagy-Mignotte H, Moro-S


2013; ():

Establishment and genetic characterization of ANGM-CSS, a novel, immortal cell line derived from a human glioblastoma multiforme.

Notarangelo A, Trombetta D, D'Angelo V., Parrella P, Palumbo O, Storlazzi CT, Impera L, Muscarella LA, La Torre A, Affuso A, Fazio VM, Carella M, Zelante L


2013; 24(4): 406-16

Hyaluronidase contributes to early inflammatory events induced by electrotransfer in mouse skeletal muscle.

Chiarella P, De Santis S, Fazio VM, Signori E


2013; 73(1): 50-8

Molecular Dissection of the VHL Gene in Solitary Capillary Hemangioblastoma of the Central Nervous System.

Muscarella LA, la Torre A, Faienza A, Catapano D, Bisceglia M, D'Angelo V, Parrella P, Coco M, Fini G, Tancredi A, Zelante L, Fazio VM, D'Agruma L


2013; 8(12): e82292

Identification and Functional Characterization of Three NoLS (Nucleolar Localisation Signals) Mutations of the CDC73 Gene

Pazienza V, la Torre A, Baorda F, Alfarano M, Chetta M, Muscarella LA, Battista C, Copetti M, Kotzot D, Kapelari K, Al-Abdulrazzaq D, Perlman K, Sochett E, Cole DE, Pellegrini F, Canaff L, Hendy GN, D'Agruma L, Zelante L, Carella M, Scillitani A, Guarnier


2013; 5(209): 209ra153

A genomics-based classification of human lung tumors.

Clinical Lung Cancer Genome Project (CLCGP), Network Genomic Medicine (NGM)


2013; 14(3): 291-9

Electroporation in DNA vaccination protocols against cancer.

Chiarella P, Fazio VM, Signori E


2013; 14(3): 279-90

In vivo DNA electrotransfer for immunotherapy of cancer and neurodegenerative diseases.

Fioretti D, Iurescia S, Fazio VM, Rinaldi M


2013; 31(32): 4140-7

A prognostic DNA methylation signature for stage I non-small-cell lung cancer.

Sandoval J, Mendez-Gonzalez J, Nadal E, Chen G, Carmona FJ, Sayols S, Moran S, Heyn H, Vizoso M, Gomez A, Sanchez-Cespedes M, Assenov Y, Müller F, Bock C, Taron M, Mora J, Muscarella LA, Liloglou T, Davies M, Pollan M, Pajares MJ, Torre W, Montuenga LM, B


2013; 5 (209ra153): 1-13

A Genomics-Based Classification of Human Lung Tumors

The Clinical Lung Cancer Genome Project (CLCGP) and Network Genomic Medicine (NGM)


2013; 14(1): S161

P1* A MIRNA SIGNATURE FOR DEFINING AGGRESSIVE PHENOTYPE AND PROGNOSIS IN GLIOMAS

Pasculli B., Barbano R., Palumbo O., Galasso M., Volinia S., D'Angelo V., Coco M., Dimitri L., Copetti M., Valori V.M., Maiello E., Carella M., Fazio V.M., Parrella P.

2013; 14(1): S111

H43 a novel rare EGFR mutation in Exon 18 showed stable disease after TKI treatment

Muscarella L.A., Parrella P., Nanni L., Di Micco C., Dimitri L.,Coco M., la Torre A., Barbano R., Maiello E., Fazio V.M.

2013; 14(1): S128

L27 MIRNA-10B as putative predictive marker of metastases development and survival for breast cancer patients

Barbano R., Pasculli B., Valori V.M., Fontana A., Copetti M., Poeta M.L., Perrone G., Pellegrini F., Onetti-Muda A., Murgo R., Maiello E., Fazio V.M., Parrella P.

2013; 5(10): 1523-36

The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.

Lucá R, Averna M, Zalfa F, Vecchi M, Bianchi F, La Fata G, Del Nonno F, Nardacci R, Bianchi M, Nuciforo P, Munck S, Parrella P, Moura R, Signori E, Alston R, Kuchnio A, Farace MG, Fazio VM, Piacentini M, De Strooper B, Achsel T, Neri G, Neven P, Evans DG,


2013; 12(7): 1058-70

Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.

Brait M, Munari E, Lebron C, Noordhuis MG, Begum S, Michailidi C, Gonzalez-Roibon N, Maldonado L, Sen T, Guerrero-Preston R, Cope L, Parrella P, Fazio VM, Ha PK, Netto GJ, Sidransky D, Hoque MO


2013; 28(2): e208-15

VHL gene alterations in Italian patients with isolated renal cell carcinomas.

Muscarella LA, D'Agruma L, la Torre A, Gigante M, Coco M, Parrella P, Battaglia M, Carrieri G, Carella M, Leopoldo Z, Fazio VM, Loreto G, Elena R, Torre AL


2012; 12(5): 547-65

BCR/ABL1 fusion transcripts generated from alternative splicing: implications for future targeted therapies in Ph+ leukaemias.

Chiarella P, Summa V, De Santis S, Signori E, Picardi E, Pesole G, Saglio G, Fazio VM


XIV National Congress of Medical Oncology 2012; Roma 27/29 ottobre 2012: D48

Gene expression analysis of somatostatin receptors in peripheral blood of small cell lung cancer affected patients and association with tumour imaging with octreoscan

D'Alessandro V, la Torre A, Muscarella LA, Copetti M, Parrella P, Tancredi A, Boragine R, Pellegrini F, La Viola M, Maiello E, Mazzoccoli G, Frusciante V, Vendemiale G, Fazio VM

2012; ():

20 novel point mutations and one large deletion in EXT1 and EXT2 genes: Report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.

Ciavarella M, Coco M, Baorda F, Stanziale P, Chetta M, Bisceglia L, Palumbo P, Bengala M, Raiteri P, Silengo M, Caldarini C, Facchini R, Lala R, Cavaliere ML, De Brasi D, Pasini B, Zelante L, Guarnieri V, D'Agruma L


2012; 8(1):

Aberrant keap1 methylation in breast cancer and association with clinicopathological features.

Barbano R, Muscarella LA, Pasculli B, Valori VM, Fontana A, Coco M, la Torre A, Balsamo T, Poeta ML, Marangi GF, Maiello E, Castelvetere M, Pellegrini F, Murgo R, Fazio VM, Parrella P


2012; 44(10): 1104-10

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Peifer M, Fernández-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, Menon R, Koker M, Dahmen I, Müller C, Di Cerbo V, Schildhaus HU, Altmüller J, Baessmann I, Becker C, de Wilde B, Vandesompele J, Böhm D, Ansén S,


2012; 27(4): e389-94

Aberrant genes promoter methylation in neural crest-derived tumors.

la Torre A, Muscarella LA, Parrella P, Balsamo T, Bisceglia M, Valori VM, la Torre A, Barbano R, Perrella E, Poeta ML, Melchionda G, Merla G, Maiello E, Pellicano R, Fazio VM


2012; 35(6): 411-22

CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort.

Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D, Baorda F, Maiello E, D'Agruma L, Chiodini I, Clemente C, Minisola S, Romagnoli E, Corbetta S, Viti R, Eller-Vainicher C, Spada A, Iacobellis M, Malavolta N, Carella M, Canaff L, Hendy GN,


2012; 25(3): 691-702

Hormone and cytokine circadian alteration in non-small cell lung cancer patients.

Mazzoccoli G, Sothern RB, Francavilla M, Giuliani F, Carughi S, Muscarella LA, Fazio VM, Parrella P, Vinciguerra M, Tarquini R


2012; 51(12): 1133-43

Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.

Poeta ML, Massi E, Parrella P, Pellegrini P, De Robertis M, Copetti M, Rabitti C, Perrone G, Muda AO, Molinari F, Zanellato E, Crippa S, Caputo D, Caricato M, Frattini M, Coppola R, Fazio VM


2012; 205(7-8): 410-3

Molecular genetic characterization of the 11q13 breakpoint in a desmoplastic fibroma of bone.

Trombetta D, Macchia G, Mandahl N, Nord KH, Mertens F


2012; 92(5): 735-43

FOSL1 as a candidate target gene for 11q12 rearrangements in desmoplastic fibroblastoma.

Macchia G, Trombetta D, Möller E, Mertens F, Storlazzi CT, Debiec-Rychter M, Sciot R, Nord KH


2011; ():

A rare S33C mutation of CTNNB1 encoding ß-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort.

Guarnieri V, Baorda F, Battista C, Bisceglia M, Balsamo T, Gruppioni E, Fiorentino M, Muscarella LA, Coco M, Barbano R, Corbetta S, Spada A, Cole DE, Canaff L, Hendy GN, Carella M, Scillitani A


2011; :

Abstract D39 - XIII Congresso Nazionale di Oncologia Medica, Bologna 2011

Muscarella LA et al.

2011; :

Abstract A25 - XIII Congresso Nazionale di Oncologia Medica, Bologna 2011

Latiano TP et al.

2011; ():

Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls.

Mazzoccoli G, Sothern RB, Parrella P, Muscarella LA, Fazio VM, Giuliani F, Polyakova V, Kvetnoy IM


2011; ():

Alteration of Hypothalamic-Pituitary-Thyroid Axis Function in Non-Small-Cell Lung Cancer Patients.

Mazzoccoli G, Pazienza V, Piepoli A, Muscarella LA, Giuliani F, Sothern RB


Biomedicine & Aging Pathology 2011; 1: 129-137

Chronobiologic study of neuro-endocrine axis hormone sequence signalling in healthy men

Mazzoccoli G, Sothern RB, Pazienza V, Piepoli A, Muscarella LA, Dagostino MP, Giuliani F

2011; ():

Circadian Aspects of Growth Hormone-Insulin-Like Growth Factor Axis Function in Patients With Lung Cancer.

Mazzoccoli G, Sothern RB, Pazienza V, Piepoli A, Muscarella LA, Giuliani F, Tarquini R


2011; 17(): 2482-94

Mutational screening of VSX1, SPARC, SOD1, LOX, and TIMP3 in keratoconus.

De Bonis P, Laborante A, Pizzicoli C, Stallone R, Barbano R, Longo C, Mazzilli E, Zelante L, Bisceglia L


2011; 79(5-6): 415-22

Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study.

Colucci G, Giuliani F, Garufi C, Mattioli R, Manzione L, Russo A, Lopez M, Parrella P, Tommasi S, Copetti M, Daniele B, Pisconti S, Tuveri G, Silvestris N, Maiello E


2011; 129(3): 536-45

High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome.

Barbano R, Copetti M, Perrone G, Pazienza V, Muscarella LA, Balsamo T, Storlazzi CT, Ripoli M, Rinaldi M, Valori VM, Latiano TP, Maiello E, Stanziale P, Carella M, Mangia A, Pellegrini F, Bisceglia M, Muda AO, Altomare V, Murgo R, Fazio VM, Parrella P


2011; ():

Antiphase signalling in the neuroendocrine-immune system in healthy humans.

Mazzoccoli G, Muscarella LA, Fazio VM, Piepoli A, Pazienza V, Dagostino MP, Giuliani F, Polyakova VO, Kvetnoy I


2011; ():

Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein.

Ripoli M, Barbano R, Balsamo T, Piccoli C, Brunetti V, Coco M, Mazzoccoli G, Vinciguerra M, Pazienza V


2011; 40(3): 481-5

Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family.

Mastroianno S, Torlontano M, Scillitani A, D'Aloiso L, Verrienti A, Bonfitto N, De Bonis A, D'Agruma L, Muscarella LA, Guarnieri V, Dicembrino F, Maranghi M, Durante C, Filetti S


Biomedicine & Aging Pathology 2011; 1: 39-45

Age-related changes of GH-IGF1 axis function

Mazzoccoli G, Inglese M, Dagostinoa MP, Piepoli A, Muscarella LA, Pazienza V, Tarquini R, Giuliani F

2011; 6(6):

Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer.

Muscarella LA, Parrella P, D'Alessandro V, la Torre A, Barbano R, Fontana A, Tancredi A, Guarnieri V, Balsamo T, Coco M, Copetti M, Pellegrini F, De Bonis P, Bisceglia M, Scaramuzzi G, Maiello E, Valori VM, Merla G, Vendemiale G, Fazio VM


2011; ():

Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.

Muscarella LA, D'Alessandro V, la Torre A, Copetti M, De Cata A, Parrella P, Sperandeo M, Pellegrini F, Frusciante V, Maiello E, Merla G, Fazio VM, Vendemiale G


2011; 6(3): 317-25

Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome.

Muscarella LA, Barbano R, D'Angelo V, Copetti M, Coco M, Balsamo T, la Torre A, Notarangelo A, Troiano M, Parisi S, Icolaro N, Catapano D, Valori VM, Pellegrini F, Merla G, Carella M, Fazio VM, Parrella P


{accordionfaq faqid=accordion3 faqclass="lightnessfaq defaulticon headerbackground headerborder contentbackground contentborder round5" active=0}

nuovo-css

webcamlive

Newsletter

Informativa Newsletter
  twitter   facebook   youtube   g plus